Assessing the causal relationship between metabolic biomarkers and coronary artery disease by Mendelian randomization studies
The development of coronary artery disease (CAD) is significantly affected by impaired endocrine and metabolic status. Under this circumstance, improved prevention and treatment of CAD may result from knowing the connection between metabolites and CAD. This study aims to delve into the causal relati...
Saved in:
| Published in: | Scientific reports Vol. 14; no. 1; pp. 19034 - 16 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
Nature Publishing Group UK
16.08.2024
Nature Publishing Group Nature Portfolio |
| Subjects: | |
| ISSN: | 2045-2322, 2045-2322 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | The development of coronary artery disease (CAD) is significantly affected by impaired endocrine and metabolic status. Under this circumstance, improved prevention and treatment of CAD may result from knowing the connection between metabolites and CAD. This study aims to delve into the causal relationship between human metabolic biomarkers and CAD by using two-sample Mendelian randomization (MR). Utilizing two-sample bidirectional MR analysis, we assessed the correlation between 1400 blood metabolites and CAD, and the metabolites data from the CLSA, encompassing 8299 participants. Metabolite analysis identified 1091 plasma metabolites and 309 ratios as instrumental variables. To evaluate the causal link between metabolites and CAD, we analyzed three datasets: ebi-a-GCST005195 (547,261 European & East Asian samples), bbj-a-159 (29,319 East Asian CAD cases & 183,134 East Asian controls), and ebi-a-GCST005194 (296,525 European & East Asian samples). To estimate causal links, we utilized the IVW method. To conduct sensitivity analysis, we used MR-Egger, Weighted Median, and MR-PRESSO. Additionally, we employed MR-Egger interception and Cochran’s Q statistic to assess potential heterogeneity and pleiotropy. What’s more, replication and reverse analyses were performed to verify the reliability of the results and the causal order between metabolites and disease. Furthermore, we conducted a pathway analysis to identify potential metabolic pathways. 59 blood metabolites and 27 metabolite ratios nominally associated with CAD (P < 0.05) were identified by IVW analysis method. A total of four known blood metabolites, namely beta-hydroxyisovaleroylcarnitine (OR 1.06, 95% CI 1.027–1.094, FDR 0.07), 1-palmitoyl-2-arachidonoyl (OR 1.07, 95% CI 1.029–1.110, FDR 0.09), 1-stearoyl-2- docosahexaenoyl (OR 1.07, 95% CI 1.034–1.113, FDR 0.07) and Linoleoyl-arachidonoyl-glycerol, (OR 1.07, 95% CI 1.036–1.105, FDR 0.05), and two metabolite ratios, namely spermidine to N-acetylputrescine ratio (OR 0.94, 95% CI 0.903–0.972, FDR 0.09) and benzoate to linoleoyl-arachidonoyl-glycerol ratio (OR 0.87, 95% CI 0.879–0.962, FDR 0.07), were confirmed as having a significant causal relationship with CAD, after correcting for the FDR method (p < 0. 1). A causal relationship was found to be established between beta -hydroxyisovalerylcarnitine and CAD with the validation in other two datasets. Moreover, multiple metabolic pathways were discovered to be associated with CAD. Our study supports the hypothesis that metabolites have an impact on CAD by demonstrating a causal relationship between human metabolites and CAD. This study is important for new strategies for the prevention and treatment of CAD. |
|---|---|
| AbstractList | The development of coronary artery disease (CAD) is significantly affected by impaired endocrine and metabolic status. Under this circumstance, improved prevention and treatment of CAD may result from knowing the connection between metabolites and CAD. This study aims to delve into the causal relationship between human metabolic biomarkers and CAD by using two-sample Mendelian randomization (MR). Utilizing two-sample bidirectional MR analysis, we assessed the correlation between 1400 blood metabolites and CAD, and the metabolites data from the CLSA, encompassing 8299 participants. Metabolite analysis identified 1091 plasma metabolites and 309 ratios as instrumental variables. To evaluate the causal link between metabolites and CAD, we analyzed three datasets: ebi-a-GCST005195 (547,261 European & East Asian samples), bbj-a-159 (29,319 East Asian CAD cases & 183,134 East Asian controls), and ebi-a-GCST005194 (296,525 European & East Asian samples). To estimate causal links, we utilized the IVW method. To conduct sensitivity analysis, we used MR-Egger, Weighted Median, and MR-PRESSO. Additionally, we employed MR-Egger interception and Cochran’s Q statistic to assess potential heterogeneity and pleiotropy. What’s more, replication and reverse analyses were performed to verify the reliability of the results and the causal order between metabolites and disease. Furthermore, we conducted a pathway analysis to identify potential metabolic pathways. 59 blood metabolites and 27 metabolite ratios nominally associated with CAD (P < 0.05) were identified by IVW analysis method. A total of four known blood metabolites, namely beta-hydroxyisovaleroylcarnitine (OR 1.06, 95% CI 1.027–1.094, FDR 0.07), 1-palmitoyl-2-arachidonoyl (OR 1.07, 95% CI 1.029–1.110, FDR 0.09), 1-stearoyl-2- docosahexaenoyl (OR 1.07, 95% CI 1.034–1.113, FDR 0.07) and Linoleoyl-arachidonoyl-glycerol, (OR 1.07, 95% CI 1.036–1.105, FDR 0.05), and two metabolite ratios, namely spermidine to N-acetylputrescine ratio (OR 0.94, 95% CI 0.903–0.972, FDR 0.09) and benzoate to linoleoyl-arachidonoyl-glycerol ratio (OR 0.87, 95% CI 0.879–0.962, FDR 0.07), were confirmed as having a significant causal relationship with CAD, after correcting for the FDR method (p < 0. 1). A causal relationship was found to be established between beta -hydroxyisovalerylcarnitine and CAD with the validation in other two datasets. Moreover, multiple metabolic pathways were discovered to be associated with CAD. Our study supports the hypothesis that metabolites have an impact on CAD by demonstrating a causal relationship between human metabolites and CAD. This study is important for new strategies for the prevention and treatment of CAD. Abstract The development of coronary artery disease (CAD) is significantly affected by impaired endocrine and metabolic status. Under this circumstance, improved prevention and treatment of CAD may result from knowing the connection between metabolites and CAD. This study aims to delve into the causal relationship between human metabolic biomarkers and CAD by using two-sample Mendelian randomization (MR). Utilizing two-sample bidirectional MR analysis, we assessed the correlation between 1400 blood metabolites and CAD, and the metabolites data from the CLSA, encompassing 8299 participants. Metabolite analysis identified 1091 plasma metabolites and 309 ratios as instrumental variables. To evaluate the causal link between metabolites and CAD, we analyzed three datasets: ebi-a-GCST005195 (547,261 European & East Asian samples), bbj-a-159 (29,319 East Asian CAD cases & 183,134 East Asian controls), and ebi-a-GCST005194 (296,525 European & East Asian samples). To estimate causal links, we utilized the IVW method. To conduct sensitivity analysis, we used MR-Egger, Weighted Median, and MR-PRESSO. Additionally, we employed MR-Egger interception and Cochran’s Q statistic to assess potential heterogeneity and pleiotropy. What’s more, replication and reverse analyses were performed to verify the reliability of the results and the causal order between metabolites and disease. Furthermore, we conducted a pathway analysis to identify potential metabolic pathways. 59 blood metabolites and 27 metabolite ratios nominally associated with CAD (P < 0.05) were identified by IVW analysis method. A total of four known blood metabolites, namely beta-hydroxyisovaleroylcarnitine (OR 1.06, 95% CI 1.027–1.094, FDR 0.07), 1-palmitoyl-2-arachidonoyl (OR 1.07, 95% CI 1.029–1.110, FDR 0.09), 1-stearoyl-2- docosahexaenoyl (OR 1.07, 95% CI 1.034–1.113, FDR 0.07) and Linoleoyl-arachidonoyl-glycerol, (OR 1.07, 95% CI 1.036–1.105, FDR 0.05), and two metabolite ratios, namely spermidine to N-acetylputrescine ratio (OR 0.94, 95% CI 0.903–0.972, FDR 0.09) and benzoate to linoleoyl-arachidonoyl-glycerol ratio (OR 0.87, 95% CI 0.879–0.962, FDR 0.07), were confirmed as having a significant causal relationship with CAD, after correcting for the FDR method (p < 0. 1). A causal relationship was found to be established between beta -hydroxyisovalerylcarnitine and CAD with the validation in other two datasets. Moreover, multiple metabolic pathways were discovered to be associated with CAD. Our study supports the hypothesis that metabolites have an impact on CAD by demonstrating a causal relationship between human metabolites and CAD. This study is important for new strategies for the prevention and treatment of CAD. The development of coronary artery disease (CAD) is significantly affected by impaired endocrine and metabolic status. Under this circumstance, improved prevention and treatment of CAD may result from knowing the connection between metabolites and CAD. This study aims to delve into the causal relationship between human metabolic biomarkers and CAD by using two-sample Mendelian randomization (MR). Utilizing two-sample bidirectional MR analysis, we assessed the correlation between 1400 blood metabolites and CAD, and the metabolites data from the CLSA, encompassing 8299 participants. Metabolite analysis identified 1091 plasma metabolites and 309 ratios as instrumental variables. To evaluate the causal link between metabolites and CAD, we analyzed three datasets: ebi-a-GCST005195 (547,261 European & East Asian samples), bbj-a-159 (29,319 East Asian CAD cases & 183,134 East Asian controls), and ebi-a-GCST005194 (296,525 European & East Asian samples). To estimate causal links, we utilized the IVW method. To conduct sensitivity analysis, we used MR-Egger, Weighted Median, and MR-PRESSO. Additionally, we employed MR-Egger interception and Cochran's Q statistic to assess potential heterogeneity and pleiotropy. What's more, replication and reverse analyses were performed to verify the reliability of the results and the causal order between metabolites and disease. Furthermore, we conducted a pathway analysis to identify potential metabolic pathways. 59 blood metabolites and 27 metabolite ratios nominally associated with CAD (P < 0.05) were identified by IVW analysis method. A total of four known blood metabolites, namely beta-hydroxyisovaleroylcarnitine (OR 1.06, 95% CI 1.027-1.094, FDR 0.07), 1-palmitoyl-2-arachidonoyl (OR 1.07, 95% CI 1.029-1.110, FDR 0.09), 1-stearoyl-2- docosahexaenoyl (OR 1.07, 95% CI 1.034-1.113, FDR 0.07) and Linoleoyl-arachidonoyl-glycerol, (OR 1.07, 95% CI 1.036-1.105, FDR 0.05), and two metabolite ratios, namely spermidine to N-acetylputrescine ratio (OR 0.94, 95% CI 0.903-0.972, FDR 0.09) and benzoate to linoleoyl-arachidonoyl-glycerol ratio (OR 0.87, 95% CI 0.879-0.962, FDR 0.07), were confirmed as having a significant causal relationship with CAD, after correcting for the FDR method (p < 0. 1). A causal relationship was found to be established between beta -hydroxyisovalerylcarnitine and CAD with the validation in other two datasets. Moreover, multiple metabolic pathways were discovered to be associated with CAD. Our study supports the hypothesis that metabolites have an impact on CAD by demonstrating a causal relationship between human metabolites and CAD. This study is important for new strategies for the prevention and treatment of CAD.The development of coronary artery disease (CAD) is significantly affected by impaired endocrine and metabolic status. Under this circumstance, improved prevention and treatment of CAD may result from knowing the connection between metabolites and CAD. This study aims to delve into the causal relationship between human metabolic biomarkers and CAD by using two-sample Mendelian randomization (MR). Utilizing two-sample bidirectional MR analysis, we assessed the correlation between 1400 blood metabolites and CAD, and the metabolites data from the CLSA, encompassing 8299 participants. Metabolite analysis identified 1091 plasma metabolites and 309 ratios as instrumental variables. To evaluate the causal link between metabolites and CAD, we analyzed three datasets: ebi-a-GCST005195 (547,261 European & East Asian samples), bbj-a-159 (29,319 East Asian CAD cases & 183,134 East Asian controls), and ebi-a-GCST005194 (296,525 European & East Asian samples). To estimate causal links, we utilized the IVW method. To conduct sensitivity analysis, we used MR-Egger, Weighted Median, and MR-PRESSO. Additionally, we employed MR-Egger interception and Cochran's Q statistic to assess potential heterogeneity and pleiotropy. What's more, replication and reverse analyses were performed to verify the reliability of the results and the causal order between metabolites and disease. Furthermore, we conducted a pathway analysis to identify potential metabolic pathways. 59 blood metabolites and 27 metabolite ratios nominally associated with CAD (P < 0.05) were identified by IVW analysis method. A total of four known blood metabolites, namely beta-hydroxyisovaleroylcarnitine (OR 1.06, 95% CI 1.027-1.094, FDR 0.07), 1-palmitoyl-2-arachidonoyl (OR 1.07, 95% CI 1.029-1.110, FDR 0.09), 1-stearoyl-2- docosahexaenoyl (OR 1.07, 95% CI 1.034-1.113, FDR 0.07) and Linoleoyl-arachidonoyl-glycerol, (OR 1.07, 95% CI 1.036-1.105, FDR 0.05), and two metabolite ratios, namely spermidine to N-acetylputrescine ratio (OR 0.94, 95% CI 0.903-0.972, FDR 0.09) and benzoate to linoleoyl-arachidonoyl-glycerol ratio (OR 0.87, 95% CI 0.879-0.962, FDR 0.07), were confirmed as having a significant causal relationship with CAD, after correcting for the FDR method (p < 0. 1). A causal relationship was found to be established between beta -hydroxyisovalerylcarnitine and CAD with the validation in other two datasets. Moreover, multiple metabolic pathways were discovered to be associated with CAD. Our study supports the hypothesis that metabolites have an impact on CAD by demonstrating a causal relationship between human metabolites and CAD. This study is important for new strategies for the prevention and treatment of CAD. |
| ArticleNumber | 19034 |
| Author | Li, Jixin Liu, Yongmei Wang, Wenru Hui, Xiaoshan Yang, Kai |
| Author_xml | – sequence: 1 givenname: Kai surname: Yang fullname: Yang, Kai organization: Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine – sequence: 2 givenname: Jixin surname: Li fullname: Li, Jixin organization: Xiyuan Hospital, China Academy of Chinese Medical Sciences – sequence: 3 givenname: Xiaoshan surname: Hui fullname: Hui, Xiaoshan organization: Guang’anmen Hospital, China Academy of Chinese Medical Sciences – sequence: 4 givenname: Wenru surname: Wang fullname: Wang, Wenru organization: Xiyuan Hospital, China Academy of Chinese Medical Sciences – sequence: 5 givenname: Yongmei surname: Liu fullname: Liu, Yongmei email: lymdoctor@163.com organization: Guang’anmen Hospital, China Academy of Chinese Medical Sciences |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39152174$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kjtvFDEUhUcoiISQP0CBLNHQDPg1D5dRBCFSEA3Ulh_XGy-z9uI7I7RI_Pc4uwmgFHFjy_rO0fH1edkcpZygaV4z-p5RMX5AyTo1tpTLtlfjoFr-rDnhVHYtF5wf_Xc-bs4Q17SujivJ1IvmWCjWcTbIk-bPOSIgxrQi8w0QZxY0EykwmTnmhDdxSyzMvwAS2cBsbJ6iIzbmjSk_oCAxyROXS06m7IgpM9TNRwSDQOyOfIHkYYomkVLJvIm_974E58VHwFfN82AmhLP7_bT5_unjt4vP7fXXy6uL8-vWybGb22HsTQh2YFwy65QFC260coQgvfNDbwcTZOiccB3ngQUjRuatFMG5XlIaxGlzdfD12az1tsQaf6eziXp_kctK1-zRTaA9KOFBdtRJLyU1th-s8pZ3FnwfmK1e7w5e25J_LoCz3kR0ME0mQV5QC6pkHX1Hh4q-fYSu81JSfekdJXolxdBX6s09tdgN-L_xHj6pAuMBcCUjFgjaxXk_x7mYOGlG9V0l9KESulZC7yuheZXyR9IH9ydF4iDCCqcVlH-xn1DdAl65zA8 |
| CitedBy_id | crossref_primary_10_1155_jnme_2292774 crossref_primary_10_2147_JIR_S528072 crossref_primary_10_1093_postmj_qgaf145 crossref_primary_10_1097_MD_0000000000040824 crossref_primary_10_3390_ijms26083572 |
| Cites_doi | 10.1016/j.jhepr.2024.101037 10.1093/nar/gky310 10.2337/db19-0153 10.1093/ije/dyx102 10.1177/0003319717690993 10.1007/s10654-017-0255-x 10.1016/0735-1097(94)90433-2 10.1161/CIRCRESAHA.117.312086 10.3389/fendo.2023.1271942 10.1016/j.clnu.2020.09.035 10.1002/jmv.28880 10.3389/fcvm.2022.965899 10.1161/CIRCGEN.121.003501 10.1038/4027 10.1016/j.atherosclerosis.2020.01.015 10.1186/s13073-022-01067-1 10.1016/j.atherosclerosis.2020.09.029 10.1007/s12350-018-01506-w 10.3389/fendo.2023.1291445 10.1016/0009-8981(95)06126-2 10.1080/10408369991239231 10.1186/s12917-016-0736-2 10.1016/j.amjmed.2022.08.012 10.3389/fcvm.2021.789458 10.1093/ije/dyv080 10.1002/gepi.22295 10.1016/j.ejim.2017.03.019 10.1038/s41588-022-01270-1 10.1016/j.bcp.2020.114065 10.2174/1568026623666221213085917 10.3390/nu15224787 10.1038/nrm.2016.25 10.1186/s12967-022-03799-5 10.1016/j.tcm.2015.03.010 10.1016/j.yjmcc.2022.05.013 10.3390/nu15071580 10.1093/ije/dyx034 10.1016/j.jacc.2020.11.010 10.1161/ATVBAHA.123.319674 10.1093/eurheartj/ehaa209 10.1186/s12916-022-02688-4 10.1161/JAHA.119.012486 10.3389/fendo.2023.1277153 10.1016/j.nut.2014.08.011 10.3390/nu15041016 10.18632/aging.102815 10.3390/nu15163593 10.1007/BF02436004 10.3389/fendo.2021.794437 10.1001/jamacardio.2017.1239 10.1038/s41569-021-00638-w 10.1002/jcp.28350 10.3389/fimmu.2022.829425 10.1002/hep.32534 10.1016/j.preteyeres.2018.11.002 10.3389/fimmu.2024.1374938 10.1016/j.jcmg.2021.06.013 10.1146/annurev.genet.34.1.233 10.1016/j.yjmcc.2018.01.013 10.1186/s12967-022-03691-2 10.1093/eurheartj/ehz859 10.1186/s12967-023-04165-9 10.1111/apt.15446 10.1016/S0021-9150(96)06044-3 10.1016/j.clnu.2005.07.003 10.1016/j.jaut.2005.03.001 10.3390/nu13010021 10.1016/j.bbrc.2011.08.073 10.3390/ijms25147706 10.1016/j.mvr.2014.08.003 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U 7X8 DOA |
| DOI | 10.1038/s41598-024-69879-2 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central (subscription) Natural Science Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Full Text url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2045-2322 |
| EndPage | 16 |
| ExternalDocumentID | oai_doaj_org_article_de93de450c4d440ab67b9db25bed6f1b 39152174 10_1038_s41598_024_69879_2 |
| Genre | Journal Article |
| GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFFHD AFPKN CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PKEHL PQEST PQUKI Q9U 7X8 PUEGO |
| ID | FETCH-LOGICAL-c485t-786affb71241bc9bebec8b48ef4dcd76b7af4f5c3c522f1fa381db43fcc6400f3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 5 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001294085700083&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2045-2322 |
| IngestDate | Fri Oct 03 12:51:17 EDT 2025 Fri Sep 05 06:55:27 EDT 2025 Tue Oct 07 09:02:36 EDT 2025 Mon Jul 21 05:41:04 EDT 2025 Tue Nov 18 21:03:34 EST 2025 Sat Nov 29 05:24:00 EST 2025 Fri Feb 21 02:37:54 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Plasma metabolites Cardiovascular disease Biomarker Mendelian randomization Risk assessment |
| Language | English |
| License | 2024. The Author(s). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c485t-786affb71241bc9bebec8b48ef4dcd76b7af4f5c3c522f1fa381db43fcc6400f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/de93de450c4d440ab67b9db25bed6f1b |
| PMID | 39152174 |
| PQID | 3093694376 |
| PQPubID | 2041939 |
| PageCount | 16 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_de93de450c4d440ab67b9db25bed6f1b proquest_miscellaneous_3094045507 proquest_journals_3093694376 pubmed_primary_39152174 crossref_citationtrail_10_1038_s41598_024_69879_2 crossref_primary_10_1038_s41598_024_69879_2 springer_journals_10_1038_s41598_024_69879_2 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-08-16 |
| PublicationDateYYYYMMDD | 2024-08-16 |
| PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-16 day: 16 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Scientific reports |
| PublicationTitleAbbrev | Sci Rep |
| PublicationTitleAlternate | Sci Rep |
| PublicationYear | 2024 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Ma, Li, An, Guo, Liu (CR13) 2023 Santos, Shapiro (CR37) 2021; 14 Xiao (CR11) 2022; 20 Akashi, Higashi, Masuda, Komori, Furuse (CR66) 2011; 413 Cheng (CR15) 2023; 15 Xu (CR23) 2023; 15 Xu (CR45) 2016; 12 Huang (CR27) 2024; 6 Kolwicz (CR52) 2021; 8 van der Harst, Verweij (CR26) 2018; 122 Wang (CR68) 2020; 178 Liang (CR18) 2023; 14 Xiong, Jiang, Li (CR44) 2022; 9 Wang (CR6) 2022; 14 Williams (CR51) 2019; 26 Ren, Simons, Wesselius, Stehouwer, Brouwers (CR5) 2023; 77 Chen (CR50) 2022; 135 Wang (CR28) 2024; 25 Burgess, Thompson (CR34) 2017; 32 Chong (CR35) 2018; 46 Gagnon (CR22) 2023; 21 Tsigkas (CR48) 2017; 68 Hung (CR53) 2020; 13 Clarke (CR36) 2022; 15 Liu (CR32) 2024; 15 Johnson, Ivanisevic, Siuzdak (CR9) 2016; 17 Li (CR21) 2020; 41 Chen (CR33) 2023; 95 Yin (CR62) 2005; 24 Wang (CR54) 2017; 2 Zhu (CR58) 2022; 13 Jia (CR20) 2019; 68 Karki, Birukov (CR56) 2021; 12 De La Barrera, Manousaki (CR16) 2023; 15 Breslow (CR40) 2000; 34 Langman, Cole (CR39) 1999; 36 Gu (CR12) 2023; 21 Malakar (CR3) 2019; 234 Doestzada (CR19) 2022; 20 Roth (CR1) 2020; 76 Papageorgiou (CR59) 2023; 23 Luo (CR69) 2022; 170 Bell, Gibson, Harshfield, Markus (CR8) 2020; 313 Yavorska, Burgess (CR25) 2017; 46 Kang (CR17) 2023; 14 Timmis (CR2) 2020; 41 Wu, Shen, Morris, Patnaik, Peter (CR55) 2005; 24 Rungoe, Nyboe Andersen, Jess (CR46) 2015; 25 Das (CR64) 2015; 31 Li, Lu, Qi, Chen, Li (CR14) 2023; 15 Chen (CR24) 2023; 55 Choi (CR47) 2019; 50 Post (CR41) 2021; 40 Bowden, Davey Smith, Burgess (CR30) 2015; 44 Adams (CR63) 1997; 129 Laíns (CR10) 2019; 69 Karvonen (CR65) 1998; 4 Guo (CR70) 2018; 116 Pu (CR67) 2020; 296 Röschinger (CR43) 1995; 240 Wang (CR61) 1994; 23 Klarin, Natarajan (CR4) 2022; 19 Caliskan (CR49) 2015; 97 Liu (CR7) 2020; 12 Appleton, Palmer, Smith, Stephens, Major (CR57) 2023; 43 Rodionov (CR60) 2019; 8 Girelli, Piubelli, Martinelli, Corrocher, Olivieri (CR38) 2017; 41 Slob, Burgess (CR29) 2020; 44 van Hove, Rutledge, Nada, Kahler, Millington (CR42) 1995; 18 Hartwig, Davey Smith, Bowden (CR31) 2017; 46 J Chong (69879_CR35) 2018; 46 H-M Liu (69879_CR7) 2020; 12 P-L Hung (69879_CR53) 2020; 13 LJ Langman (69879_CR39) 1999; 36 YJ Choi (69879_CR47) 2019; 50 BD Appleton (69879_CR57) 2023; 43 UN Das (69879_CR64) 2015; 31 M Akashi (69879_CR66) 2011; 413 T Luo (69879_CR69) 2022; 170 Z Ren (69879_CR5) 2023; 77 K Guo (69879_CR70) 2018; 116 Q Ma (69879_CR13) 2023 P van der Harst (69879_CR26) 2018; 122 H Liang (69879_CR18) 2023; 14 FP Hartwig (69879_CR31) 2017; 46 D Klarin (69879_CR4) 2022; 19 H Cheng (69879_CR15) 2023; 15 S Wang (69879_CR28) 2024; 25 H Chen (69879_CR33) 2023; 95 A Post (69879_CR41) 2021; 40 J Jia (69879_CR20) 2019; 68 SL Clarke (69879_CR36) 2022; 15 J Kang (69879_CR17) 2023; 14 B De La Barrera (69879_CR16) 2023; 15 M Doestzada (69879_CR19) 2022; 20 W-H Yin (69879_CR62) 2005; 24 E Gagnon (69879_CR22) 2023; 21 JL Breslow (69879_CR40) 2000; 34 CH Johnson (69879_CR9) 2016; 17 MK Karvonen (69879_CR65) 1998; 4 OO Yavorska (69879_CR25) 2017; 46 D Girelli (69879_CR38) 2017; 41 J Xu (69879_CR45) 2016; 12 GA Roth (69879_CR1) 2020; 76 JL van Hove (69879_CR42) 1995; 18 I Laíns (69879_CR10) 2019; 69 X Li (69879_CR14) 2023; 15 MR Adams (69879_CR63) 1997; 129 EAW Slob (69879_CR29) 2020; 44 AK Malakar (69879_CR3) 2019; 234 G Xiao (69879_CR11) 2022; 20 Y Chen (69879_CR24) 2023; 55 SC Kolwicz (69879_CR52) 2021; 8 Q Liu (69879_CR32) 2024; 15 N Papageorgiou (69879_CR59) 2023; 23 X Pu (69879_CR67) 2020; 296 S Bell (69879_CR8) 2020; 313 W Huang (69879_CR27) 2024; 6 S Burgess (69879_CR34) 2017; 32 B Chen (69879_CR50) 2022; 135 C Rungoe (69879_CR46) 2015; 25 H Xu (69879_CR23) 2023; 15 RD Santos (69879_CR37) 2021; 14 K Wang (69879_CR6) 2022; 14 A Timmis (69879_CR2) 2020; 41 J Li (69879_CR21) 2020; 41 W Röschinger (69879_CR43) 1995; 240 RN Rodionov (69879_CR60) 2019; 8 Y Xiong (69879_CR44) 2022; 9 Z Caliskan (69879_CR49) 2015; 97 R Wu (69879_CR55) 2005; 24 KA Williams (69879_CR51) 2019; 26 G Tsigkas (69879_CR48) 2017; 68 P Karki (69879_CR56) 2021; 12 H Wang (69879_CR54) 2017; 2 J Bowden (69879_CR30) 2015; 44 Q Zhu (69879_CR58) 2022; 13 Y Gu (69879_CR12) 2023; 21 BY Wang (69879_CR61) 1994; 23 J Wang (69879_CR68) 2020; 178 |
| References_xml | – volume: 6 start-page: 101037 year: 2024 ident: CR27 article-title: Investigating shared genetic architecture between inflammatory bowel diseases and primary biliary cholangitis publication-title: JHEP Rep. doi: 10.1016/j.jhepr.2024.101037 – volume: 46 start-page: W486 year: 2018 end-page: W494 ident: CR35 article-title: MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis publication-title: Nucleic Acids Res. doi: 10.1093/nar/gky310 – volume: 68 start-page: 1747 year: 2019 end-page: 1755 ident: CR20 article-title: Assessment of causal direction between gut microbiota-dependent metabolites and cardiometabolic health: A bidirectional Mendelian randomization analysis publication-title: Diabetes doi: 10.2337/db19-0153 – volume: 46 start-page: 1985 year: 2017 end-page: 1998 ident: CR31 article-title: Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption publication-title: Int. J. Epidemiol. doi: 10.1093/ije/dyx102 – volume: 68 start-page: 845 year: 2017 end-page: 849 ident: CR48 article-title: Inflammatory bowel disease: A potential risk factor for coronary artery disease publication-title: Angiology doi: 10.1177/0003319717690993 – volume: 32 start-page: 377 year: 2017 end-page: 389 ident: CR34 article-title: Interpreting findings from Mendelian randomization using the MR-Egger method publication-title: Eur. J. Epidemiol. doi: 10.1007/s10654-017-0255-x – volume: 23 start-page: 452 year: 1994 end-page: 458 ident: CR61 article-title: Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit publication-title: J. Am. Coll. Cardiol. doi: 10.1016/0735-1097(94)90433-2 – volume: 122 start-page: 433 year: 2018 end-page: 443 ident: CR26 article-title: Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.117.312086 – volume: 14 start-page: 1271942 year: 2023 ident: CR17 article-title: The association of lipid metabolism with bone metabolism and the role of human traits: A Mendelian randomization study publication-title: Front. Endocrinol. (Lausanne) doi: 10.3389/fendo.2023.1271942 – volume: 40 start-page: 2109 year: 2021 end-page: 2120 ident: CR41 article-title: Urinary 3-hydroxyisovaleryl carnitine excretion, protein energy malnutrition and risk of all-cause mortality in kidney transplant recipients: Results from the TransplantLines cohort studies publication-title: Clin. Nutr. doi: 10.1016/j.clnu.2020.09.035 – volume: 95 start-page: e28880 year: 2023 ident: CR33 article-title: The causal role of gut microbiota in susceptibility and severity of COVID-19: A bidirectional Mendelian randomization study publication-title: J. Med. Virol. doi: 10.1002/jmv.28880 – volume: 9 start-page: 965899 year: 2022 ident: CR44 article-title: Aberrant branched-chain amino acid catabolism in cardiovascular diseases publication-title: Front. Cardiovasc. Med. doi: 10.3389/fcvm.2022.965899 – volume: 15 start-page: e003501 year: 2022 ident: CR36 article-title: Coronary artery disease risk of familial hypercholesterolemia genetic variants independent of clinically observed longitudinal cholesterol exposure publication-title: Circ. Genom. Precis. Med. doi: 10.1161/CIRCGEN.121.003501 – volume: 4 start-page: 1434 year: 1998 end-page: 1437 ident: CR65 article-title: Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels publication-title: Nat. Med. doi: 10.1038/4027 – volume: 296 start-page: 11 year: 2020 end-page: 17 ident: CR67 article-title: Effect of a coronary-heart-disease-associated variant of ADAMTS7 on endothelial cell angiogenesis publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2020.01.015 – volume: 14 start-page: 63 year: 2022 ident: CR6 article-title: Mendelian randomization analysis of 37 clinical factors and coronary artery disease in East Asian and European populations publication-title: Genome Med. doi: 10.1186/s13073-022-01067-1 – volume: 313 start-page: 111 year: 2020 end-page: 117 ident: CR8 article-title: Is periodontitis a risk factor for ischaemic stroke, coronary artery disease and subclinical atherosclerosis? A Mendelian randomization study publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2020.09.029 – volume: 26 start-page: 86 year: 2019 end-page: 91 ident: CR51 article-title: Nutrition, risk factors, prevention, and imaging: The 2018 Mario Verani Lecture publication-title: J. Nucl. Cardiol. doi: 10.1007/s12350-018-01506-w – year: 2023 ident: CR13 article-title: Assessment of causal association between differentiated thyroid cancer and disordered serum lipid profile: A Mendelian randomization study publication-title: Front. Endocrinol. doi: 10.3389/fendo.2023.1291445 – volume: 240 start-page: 35 year: 1995 end-page: 51 ident: CR43 article-title: 3-Hydroxyisovalerylcarnitine in patients with deficiency of 3-methylcrotonyl CoA carboxylase publication-title: Clin. Chim. Acta doi: 10.1016/0009-8981(95)06126-2 – volume: 36 start-page: 365 year: 1999 end-page: 406 ident: CR39 article-title: Homocysteine publication-title: Crit. Rev. Clin. Lab. Sci. doi: 10.1080/10408369991239231 – volume: 12 start-page: 114 year: 2016 ident: CR45 article-title: Does canine inflammatory bowel disease influence gut microbial profile and host metabolism? publication-title: BMC Vet. Res. doi: 10.1186/s12917-016-0736-2 – volume: 135 start-page: 1453 year: 2022 end-page: 1460 ident: CR50 article-title: Inflammatory bowel disease and cardiovascular diseases publication-title: Am. J. Med. doi: 10.1016/j.amjmed.2022.08.012 – volume: 8 start-page: 789458 year: 2021 ident: CR52 article-title: Ketone body metabolism in the ischemic heart publication-title: Front. Cardiovasc. Med. doi: 10.3389/fcvm.2021.789458 – volume: 44 start-page: 512 year: 2015 end-page: 525 ident: CR30 article-title: Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression publication-title: Int. J. Epidemiol. doi: 10.1093/ije/dyv080 – volume: 44 start-page: 313 year: 2020 end-page: 329 ident: CR29 article-title: A comparison of robust Mendelian randomization methods using summary data publication-title: Genet. Epidemiol. doi: 10.1002/gepi.22295 – volume: 41 start-page: 10 year: 2017 end-page: 17 ident: CR38 article-title: A decade of progress on the genetic basis of coronary artery disease. Practical insights for the internist publication-title: Eur. J. Intern. Med. doi: 10.1016/j.ejim.2017.03.019 – volume: 55 start-page: 44 year: 2023 end-page: 53 ident: CR24 article-title: Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases publication-title: Nat. Genet. doi: 10.1038/s41588-022-01270-1 – volume: 178 start-page: 114065 year: 2020 ident: CR68 article-title: Proline improves cardiac remodeling following myocardial infarction and attenuates cardiomyocyte apoptosis via redox regulation publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2020.114065 – volume: 23 start-page: 470 year: 2023 end-page: 480 ident: CR59 article-title: Asymmetric dimethylarginine as a biomarker in coronary artery disease publication-title: Curr. Top. Med. Chem. doi: 10.2174/1568026623666221213085917 – volume: 15 start-page: 4787 year: 2023 ident: CR14 article-title: The role of polyunsaturated fatty acids in osteoarthritis: Insights from a Mendelian randomization study publication-title: Nutrients doi: 10.3390/nu15224787 – volume: 17 start-page: 451 year: 2016 end-page: 459 ident: CR9 article-title: Metabolomics: Beyond biomarkers and towards mechanisms publication-title: Nat. Rev. Mol. Cell. Biol. doi: 10.1038/nrm.2016.25 – volume: 21 start-page: 60 year: 2023 ident: CR22 article-title: Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: A Mendelian randomization study publication-title: J. Transl. Med. doi: 10.1186/s12967-022-03799-5 – volume: 25 start-page: 699 year: 2015 end-page: 704 ident: CR46 article-title: Inflammatory bowel disease and risk of coronary heart disease publication-title: Trends Cardiovasc. Med. doi: 10.1016/j.tcm.2015.03.010 – volume: 170 start-page: 60 year: 2022 end-page: 74 ident: CR69 article-title: Deficiency of proline/serine-rich coiled-coil protein 1 (PSRC1) accelerates trimethylamine N-oxide-induced atherosclerosis in ApoE-/- mice publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2022.05.013 – volume: 15 start-page: 1580 year: 2023 ident: CR23 article-title: Association of circulating branched-chain amino acids with cardiovascular diseases: A Mendelian randomization study publication-title: Nutrients doi: 10.3390/nu15071580 – volume: 46 start-page: 1734 year: 2017 end-page: 1739 ident: CR25 article-title: MendelianRandomization: An R package for performing Mendelian randomization analyses using summarized data publication-title: Int. J. Epidemiol. doi: 10.1093/ije/dyx034 – volume: 76 start-page: 2982 year: 2020 end-page: 3021 ident: CR1 article-title: Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2020.11.010 – volume: 43 start-page: 2119 year: 2023 end-page: 2132 ident: CR57 article-title: Oxidized phospholipid oxPAPC alters regulatory T-cell differentiation and decreases their protective function in atherosclerosis in mice publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.123.319674 – volume: 41 start-page: 2645 year: 2020 end-page: 2656 ident: CR21 article-title: The Mediterranean diet, plasma metabolome, and cardiovascular disease risk publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehaa209 – volume: 20 start-page: 485 year: 2022 ident: CR19 article-title: Systematic analysis of relationships between plasma branched-chain amino acid concentrations and cardiometabolic parameters: An association and Mendelian randomization study publication-title: BMC Med. doi: 10.1186/s12916-022-02688-4 – volume: 8 start-page: e012486 year: 2019 ident: CR60 article-title: Homoarginine supplementation prevents left ventricular dilatation and preserves systolic function in a model of coronary artery disease publication-title: J. Am. Heart Assoc. doi: 10.1161/JAHA.119.012486 – volume: 14 start-page: 1277153 year: 2023 ident: CR18 article-title: Causal relationship between linoleic acid and type 2 diabetes and glycemic traits: A bidirectional Mendelian randomization study publication-title: Front. Endocrinol. (Lausanne) doi: 10.3389/fendo.2023.1277153 – volume: 31 start-page: 283 year: 2015 end-page: 291 ident: CR64 article-title: Nutritional factors in the prevention and management of coronary artery disease and heart failure publication-title: Nutrition doi: 10.1016/j.nut.2014.08.011 – volume: 15 start-page: 1016 year: 2023 ident: CR16 article-title: Serum 25-hydroxyvitamin D levels and youth-onset type 2 diabetes: A two-sample Mendelian randomization study publication-title: Nutrients doi: 10.3390/nu15041016 – volume: 12 start-page: 3340 year: 2020 end-page: 3353 ident: CR7 article-title: Sarcopenia-related traits and coronary artery disease: A bi-directional Mendelian randomization study publication-title: Aging (Albany NY) doi: 10.18632/aging.102815 – volume: 15 start-page: 3593 year: 2023 ident: CR15 article-title: Association of 25-hydroxyvitamin D with preterm birth and premature rupture of membranes: A Mendelian randomization study publication-title: Nutrients doi: 10.3390/nu15163593 – volume: 18 start-page: 592 year: 1995 end-page: 601 ident: CR42 article-title: 3-Hydroxyisovalerylcarnitine in 3-methylcrotonyl-CoA carboxylase deficiency publication-title: J. Inherit. Metab. Dis. doi: 10.1007/BF02436004 – volume: 12 start-page: 794437 year: 2021 ident: CR56 article-title: Oxidized phospholipids in control of endothelial barrier function: Mechanisms and implication in lung injury publication-title: Front. Endocrinol. (Lausanne) doi: 10.3389/fendo.2021.794437 – volume: 2 start-page: 896 year: 2017 end-page: 901 ident: CR54 article-title: Sildenafil treatment in heart failure with preserved ejection fraction: Targeted metabolomic profiling in the RELAX trial publication-title: JAMA Cardiol. doi: 10.1001/jamacardio.2017.1239 – volume: 19 start-page: 291 year: 2022 end-page: 301 ident: CR4 article-title: Clinical utility of polygenic risk scores for coronary artery disease publication-title: Nat. Rev. Cardiol. doi: 10.1038/s41569-021-00638-w – volume: 234 start-page: 16812 year: 2019 end-page: 16823 ident: CR3 article-title: A review on coronary artery disease, its risk factors, and therapeutics publication-title: J. Cell. Physiol. doi: 10.1002/jcp.28350 – volume: 13 start-page: 829425 year: 2022 ident: CR58 article-title: Comprehensive metabolic profiling of inflammation indicated key roles of glycerophospholipid and arginine metabolism in coronary artery disease publication-title: Front. Immunol. doi: 10.3389/fimmu.2022.829425 – volume: 77 start-page: 230 year: 2023 end-page: 238 ident: CR5 article-title: Relationship between NAFLD and coronary artery disease: A Mendelian randomization study publication-title: Hepatology doi: 10.1002/hep.32534 – volume: 69 start-page: 57 year: 2019 end-page: 79 ident: CR10 article-title: Metabolomics in the study of retinal health and disease publication-title: Prog. Retin. Eye Res. doi: 10.1016/j.preteyeres.2018.11.002 – volume: 15 start-page: 1374938 year: 2024 ident: CR32 article-title: Exploring risk factors for autoimmune diseases complicated by non-hodgkin lymphoma through regulatory T cell immune-related traits: A Mendelian randomization study publication-title: Front. Immunol. doi: 10.3389/fimmu.2024.1374938 – volume: 14 start-page: 2425 year: 2021 end-page: 2428 ident: CR37 article-title: Coronary artery calcification and risk stratification in familial hypercholesterolemia: Moving forward but not there yet publication-title: JACC Cardiovasc. Imaging doi: 10.1016/j.jcmg.2021.06.013 – volume: 34 start-page: 233 year: 2000 end-page: 254 ident: CR40 article-title: Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility publication-title: Annu. Rev. Genet. doi: 10.1146/annurev.genet.34.1.233 – volume: 116 start-page: 69 year: 2018 end-page: 80 ident: CR70 article-title: PSRC1 overexpression attenuates atherosclerosis progression in apoE-/- mice by modulating cholesterol transportation and inflammation publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2018.01.013 – volume: 20 start-page: 475 year: 2022 ident: CR11 article-title: Causality of genetically determined metabolites on anxiety disorders: A two-sample Mendelian randomization study publication-title: J. Transl. Med. doi: 10.1186/s12967-022-03691-2 – volume: 41 start-page: 12 year: 2020 end-page: 85 ident: CR2 article-title: European society of cardiology: Cardiovascular disease statistics 2019 publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehz859 – volume: 21 start-page: 357 year: 2023 ident: CR12 article-title: Causality of genetically determined metabolites and metabolic pathways on osteoarthritis: A two-sample mendelian randomization study publication-title: J. Transl. Med. doi: 10.1186/s12967-023-04165-9 – volume: 50 start-page: 769 year: 2019 end-page: 779 ident: CR47 article-title: Patients with inflammatory bowel disease have an increased risk of myocardial infarction: A nationwide study publication-title: Aliment. Pharmacol. Ther. doi: 10.1111/apt.15446 – volume: 129 start-page: 261 year: 1997 end-page: 269 ident: CR63 article-title: Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease publication-title: Atherosclerosis doi: 10.1016/S0021-9150(96)06044-3 – volume: 24 start-page: 988 year: 2005 end-page: 997 ident: CR62 article-title: L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease publication-title: Clin. Nutr. doi: 10.1016/j.clnu.2005.07.003 – volume: 24 start-page: 353 year: 2005 end-page: 360 ident: CR55 article-title: Elevated autoantibodies against oxidized palmitoyl arachidonoyl phosphocholine in patients with hypertension and myocardial infarction publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2005.03.001 – volume: 13 start-page: 21 year: 2020 ident: CR53 article-title: An examination of serum acylcarnitine and amino acid profiles at different time point of ketogenic diet therapy and their association of ketogenic diet effectiveness publication-title: Nutrients doi: 10.3390/nu13010021 – volume: 413 start-page: 224 year: 2011 end-page: 229 ident: CR66 article-title: A coronary artery disease-associated gene product, JCAD/KIAA1462, is a novel component of endothelial cell-cell junctions publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2011.08.073 – volume: 25 start-page: 7706 year: 2024 ident: CR28 article-title: Genetically Predicted peripheral immune cells mediate the effect of gut microbiota on influenza susceptibility publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms25147706 – volume: 97 start-page: 25 year: 2015 end-page: 30 ident: CR49 article-title: Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease publication-title: Microvasc. Res. doi: 10.1016/j.mvr.2014.08.003 – volume: 44 start-page: 512 year: 2015 ident: 69879_CR30 publication-title: Int. J. Epidemiol. doi: 10.1093/ije/dyv080 – volume: 46 start-page: 1734 year: 2017 ident: 69879_CR25 publication-title: Int. J. Epidemiol. doi: 10.1093/ije/dyx034 – volume: 116 start-page: 69 year: 2018 ident: 69879_CR70 publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2018.01.013 – volume: 68 start-page: 845 year: 2017 ident: 69879_CR48 publication-title: Angiology doi: 10.1177/0003319717690993 – volume: 9 start-page: 965899 year: 2022 ident: 69879_CR44 publication-title: Front. Cardiovasc. Med. doi: 10.3389/fcvm.2022.965899 – volume: 68 start-page: 1747 year: 2019 ident: 69879_CR20 publication-title: Diabetes doi: 10.2337/db19-0153 – volume: 20 start-page: 485 year: 2022 ident: 69879_CR19 publication-title: BMC Med. doi: 10.1186/s12916-022-02688-4 – volume: 8 start-page: e012486 year: 2019 ident: 69879_CR60 publication-title: J. Am. Heart Assoc. doi: 10.1161/JAHA.119.012486 – volume: 46 start-page: W486 year: 2018 ident: 69879_CR35 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gky310 – volume: 95 start-page: e28880 year: 2023 ident: 69879_CR33 publication-title: J. Med. Virol. doi: 10.1002/jmv.28880 – volume: 413 start-page: 224 year: 2011 ident: 69879_CR66 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2011.08.073 – volume: 40 start-page: 2109 year: 2021 ident: 69879_CR41 publication-title: Clin. Nutr. doi: 10.1016/j.clnu.2020.09.035 – volume: 21 start-page: 357 year: 2023 ident: 69879_CR12 publication-title: J. Transl. Med. doi: 10.1186/s12967-023-04165-9 – volume: 21 start-page: 60 year: 2023 ident: 69879_CR22 publication-title: J. Transl. Med. doi: 10.1186/s12967-022-03799-5 – volume: 240 start-page: 35 year: 1995 ident: 69879_CR43 publication-title: Clin. Chim. Acta doi: 10.1016/0009-8981(95)06126-2 – volume: 8 start-page: 789458 year: 2021 ident: 69879_CR52 publication-title: Front. Cardiovasc. Med. doi: 10.3389/fcvm.2021.789458 – volume: 135 start-page: 1453 year: 2022 ident: 69879_CR50 publication-title: Am. J. Med. doi: 10.1016/j.amjmed.2022.08.012 – volume: 23 start-page: 470 year: 2023 ident: 69879_CR59 publication-title: Curr. Top. Med. Chem. doi: 10.2174/1568026623666221213085917 – volume: 12 start-page: 794437 year: 2021 ident: 69879_CR56 publication-title: Front. Endocrinol. (Lausanne) doi: 10.3389/fendo.2021.794437 – volume: 25 start-page: 7706 year: 2024 ident: 69879_CR28 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms25147706 – volume: 36 start-page: 365 year: 1999 ident: 69879_CR39 publication-title: Crit. Rev. Clin. Lab. Sci. doi: 10.1080/10408369991239231 – volume: 76 start-page: 2982 year: 2020 ident: 69879_CR1 publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2020.11.010 – volume: 15 start-page: 3593 year: 2023 ident: 69879_CR15 publication-title: Nutrients doi: 10.3390/nu15163593 – volume: 6 start-page: 101037 year: 2024 ident: 69879_CR27 publication-title: JHEP Rep. doi: 10.1016/j.jhepr.2024.101037 – volume: 26 start-page: 86 year: 2019 ident: 69879_CR51 publication-title: J. Nucl. Cardiol. doi: 10.1007/s12350-018-01506-w – volume: 43 start-page: 2119 year: 2023 ident: 69879_CR57 publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.123.319674 – volume: 313 start-page: 111 year: 2020 ident: 69879_CR8 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2020.09.029 – volume: 13 start-page: 829425 year: 2022 ident: 69879_CR58 publication-title: Front. Immunol. doi: 10.3389/fimmu.2022.829425 – volume: 122 start-page: 433 year: 2018 ident: 69879_CR26 publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.117.312086 – volume: 296 start-page: 11 year: 2020 ident: 69879_CR67 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2020.01.015 – volume: 50 start-page: 769 year: 2019 ident: 69879_CR47 publication-title: Aliment. Pharmacol. Ther. doi: 10.1111/apt.15446 – volume: 12 start-page: 3340 year: 2020 ident: 69879_CR7 publication-title: Aging (Albany NY) doi: 10.18632/aging.102815 – year: 2023 ident: 69879_CR13 publication-title: Front. Endocrinol. doi: 10.3389/fendo.2023.1291445 – volume: 46 start-page: 1985 year: 2017 ident: 69879_CR31 publication-title: Int. J. Epidemiol. doi: 10.1093/ije/dyx102 – volume: 23 start-page: 452 year: 1994 ident: 69879_CR61 publication-title: J. Am. Coll. Cardiol. doi: 10.1016/0735-1097(94)90433-2 – volume: 15 start-page: e003501 year: 2022 ident: 69879_CR36 publication-title: Circ. Genom. Precis. Med. doi: 10.1161/CIRCGEN.121.003501 – volume: 24 start-page: 353 year: 2005 ident: 69879_CR55 publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2005.03.001 – volume: 170 start-page: 60 year: 2022 ident: 69879_CR69 publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2022.05.013 – volume: 24 start-page: 988 year: 2005 ident: 69879_CR62 publication-title: Clin. Nutr. doi: 10.1016/j.clnu.2005.07.003 – volume: 14 start-page: 1277153 year: 2023 ident: 69879_CR18 publication-title: Front. Endocrinol. (Lausanne) doi: 10.3389/fendo.2023.1277153 – volume: 41 start-page: 10 year: 2017 ident: 69879_CR38 publication-title: Eur. J. Intern. Med. doi: 10.1016/j.ejim.2017.03.019 – volume: 15 start-page: 4787 year: 2023 ident: 69879_CR14 publication-title: Nutrients doi: 10.3390/nu15224787 – volume: 20 start-page: 475 year: 2022 ident: 69879_CR11 publication-title: J. Transl. Med. doi: 10.1186/s12967-022-03691-2 – volume: 25 start-page: 699 year: 2015 ident: 69879_CR46 publication-title: Trends Cardiovasc. Med. doi: 10.1016/j.tcm.2015.03.010 – volume: 55 start-page: 44 year: 2023 ident: 69879_CR24 publication-title: Nat. Genet. doi: 10.1038/s41588-022-01270-1 – volume: 15 start-page: 1374938 year: 2024 ident: 69879_CR32 publication-title: Front. Immunol. doi: 10.3389/fimmu.2024.1374938 – volume: 129 start-page: 261 year: 1997 ident: 69879_CR63 publication-title: Atherosclerosis doi: 10.1016/S0021-9150(96)06044-3 – volume: 34 start-page: 233 year: 2000 ident: 69879_CR40 publication-title: Annu. Rev. Genet. doi: 10.1146/annurev.genet.34.1.233 – volume: 2 start-page: 896 year: 2017 ident: 69879_CR54 publication-title: JAMA Cardiol. doi: 10.1001/jamacardio.2017.1239 – volume: 14 start-page: 2425 year: 2021 ident: 69879_CR37 publication-title: JACC Cardiovasc. Imaging doi: 10.1016/j.jcmg.2021.06.013 – volume: 41 start-page: 2645 year: 2020 ident: 69879_CR21 publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehaa209 – volume: 234 start-page: 16812 year: 2019 ident: 69879_CR3 publication-title: J. Cell. Physiol. doi: 10.1002/jcp.28350 – volume: 77 start-page: 230 year: 2023 ident: 69879_CR5 publication-title: Hepatology doi: 10.1002/hep.32534 – volume: 32 start-page: 377 year: 2017 ident: 69879_CR34 publication-title: Eur. J. Epidemiol. doi: 10.1007/s10654-017-0255-x – volume: 18 start-page: 592 year: 1995 ident: 69879_CR42 publication-title: J. Inherit. Metab. Dis. doi: 10.1007/BF02436004 – volume: 69 start-page: 57 year: 2019 ident: 69879_CR10 publication-title: Prog. Retin. Eye Res. doi: 10.1016/j.preteyeres.2018.11.002 – volume: 97 start-page: 25 year: 2015 ident: 69879_CR49 publication-title: Microvasc. Res. doi: 10.1016/j.mvr.2014.08.003 – volume: 13 start-page: 21 year: 2020 ident: 69879_CR53 publication-title: Nutrients doi: 10.3390/nu13010021 – volume: 41 start-page: 12 year: 2020 ident: 69879_CR2 publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehz859 – volume: 4 start-page: 1434 year: 1998 ident: 69879_CR65 publication-title: Nat. Med. doi: 10.1038/4027 – volume: 15 start-page: 1016 year: 2023 ident: 69879_CR16 publication-title: Nutrients doi: 10.3390/nu15041016 – volume: 31 start-page: 283 year: 2015 ident: 69879_CR64 publication-title: Nutrition doi: 10.1016/j.nut.2014.08.011 – volume: 14 start-page: 1271942 year: 2023 ident: 69879_CR17 publication-title: Front. Endocrinol. (Lausanne) doi: 10.3389/fendo.2023.1271942 – volume: 178 start-page: 114065 year: 2020 ident: 69879_CR68 publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2020.114065 – volume: 14 start-page: 63 year: 2022 ident: 69879_CR6 publication-title: Genome Med. doi: 10.1186/s13073-022-01067-1 – volume: 15 start-page: 1580 year: 2023 ident: 69879_CR23 publication-title: Nutrients doi: 10.3390/nu15071580 – volume: 17 start-page: 451 year: 2016 ident: 69879_CR9 publication-title: Nat. Rev. Mol. Cell. Biol. doi: 10.1038/nrm.2016.25 – volume: 44 start-page: 313 year: 2020 ident: 69879_CR29 publication-title: Genet. Epidemiol. doi: 10.1002/gepi.22295 – volume: 19 start-page: 291 year: 2022 ident: 69879_CR4 publication-title: Nat. Rev. Cardiol. doi: 10.1038/s41569-021-00638-w – volume: 12 start-page: 114 year: 2016 ident: 69879_CR45 publication-title: BMC Vet. Res. doi: 10.1186/s12917-016-0736-2 |
| SSID | ssj0000529419 |
| Score | 2.4555182 |
| Snippet | The development of coronary artery disease (CAD) is significantly affected by impaired endocrine and metabolic status. Under this circumstance, improved... Abstract The development of coronary artery disease (CAD) is significantly affected by impaired endocrine and metabolic status. Under this circumstance,... |
| SourceID | doaj proquest pubmed crossref springer |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 19034 |
| SubjectTerms | 631/114 631/208 692/163 692/4019 692/499 692/53 Asian People - genetics Benzoic acid Biomarker Biomarkers Biomarkers - blood Blood Cardiovascular disease Coronary artery disease Coronary Artery Disease - blood Coronary Artery Disease - genetics Coronary Artery Disease - metabolism Coronary vessels Female Glycerol Heart diseases Heterogeneity Humanities and Social Sciences Humans Interception Male Mendelian randomization Mendelian Randomization Analysis Metabolic pathways Metabolism Metabolites Metabolomics - methods multidisciplinary Plasma metabolites Pleiotropy Prevention Ratios Risk assessment Science Science (multidisciplinary) Sensitivity analysis Spermidine Vein & artery diseases |
| SummonAdditionalLinks | – databaseName: Science Database dbid: M2P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9UwEB5BAYkL-xIoyEjcwGoSO4lzQoCoONCqB5B6s7zCk9rkkbyH9A78dzyOkwoBvXBN7NjRLB7P8g3Ay9LlQufOUiaqknLDCqprLmhQCxzrJqvcR3T9T83xsTg9bU-Sw21MaZWzToyK2vYGfeQHGLELk4M8vFl_p9g1CqOrqYXGVbgWLJsCU7qOypPFx4JRLF60qVYmZ-JgDKtjTVnJaR1u2y0tfzuPImz_32zNP-Kk8fg5vP2_G78Dt5LhSd5OnHIXrrjuHtyYWlHu7sPPKfob1ibBJCRGbccwephT5b6t1iSldJFztwmcc7YyBGv3Mb1nGInqLDGIhqCGHYl5ojuSgj9E78gRetrRo0LC2Wj781T9ScYpjfEBfDn88Pn9R5paM1DDRbWhjaiV97oJ1kGhTauRFYTmwnlujW1q3SjPfWWYCfadL7wKhoHVnHlj6qA1PHsIe13fucdACmxbylXBsOMHc1znwaSyWgnTqlJxlUExE0iahFuO7TPOZIyfMyEnospAVBmJKssMXi1z1hNqx6Wj3yHdl5GIuB0f9MNXmQRYWtcy63iVG245z5WuG91aXVba2doXOoP9mfwyqYFRXtA-gxfL6yDAGJVRneu3cQzPsba8yeDRxG3LThC9H--MGbye2e_i4__-oSeX7-Up3CxRAhDYt96Hvc2wdc_guvmxWY3D8yhCvwDKfyS4 priority: 102 providerName: ProQuest |
| Title | Assessing the causal relationship between metabolic biomarkers and coronary artery disease by Mendelian randomization studies |
| URI | https://link.springer.com/article/10.1038/s41598-024-69879-2 https://www.ncbi.nlm.nih.gov/pubmed/39152174 https://www.proquest.com/docview/3093694376 https://www.proquest.com/docview/3094045507 https://doaj.org/article/de93de450c4d440ab67b9db25bed6f1b |
| Volume | 14 |
| WOSCitedRecordID | wos001294085700083&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Open Access Full Text customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M7P dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: 7X7 dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: BENPR dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: PIMPY dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M2P dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZgFyQuiDeBpTISN4g2sZ3YObJoVyDRKkIglVPkp6i0266SFqkH_jszdloW8bpw8SGxE9sz9ow9M98Q8oL5QpnCu5yriuXC8jI3tVA5bAsC4yarIkR0_fdyNlPzedNeSfWFPmEJHjhN3LHzDXdeVIUVTohCm1qaxhlWGe_qUBrcfQvZXDlMJVRvBj9qxiiZgqvjAf6L0WRM5DWcs5uc_SSJImD_77TMXyykUfCc3SG3R42Rvk49vUuu-eU9cjPlkNzeJ9-S2RaaUtDlqNWbAWr3Ox-3L4tLOvpi0Qu_BpKfLyzFoHv0y-kHqpeOWoQx0P2WRgfPLR2tNtRs6RSvyPEqhIJQc6uLMWyTDsn_8AH5dHb68c3bfMypkFuhqnUuVa1DMBLEemlsY5CGygjlg3DWydpIHUSoLLegmIUyaJDozggerK1huQf-kBwsV0v_mNAS840KXXJM1cG9MAXoQs5oZRvNtNAZKXfz29kRcBzzXpx30fDNVZdo0gFNukiTjmXk5b7NZYLb-GvtEyTbviZCZccHwEDdyEDdvxgoI0c7onfj-h06tA8Dq8Lum5Hn-9ew8tCcopd-tYl1RIFB4TIjjxKz7HuCsPt42MvIqx33_Pj4nwf05H8M6Cm5xZDNEbe3PiIH637jn5Eb9ut6MfQTcl3OZSzVhByenM7aD5O4dqCcshZLCeVh-27afv4OPH8fIQ |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VAoIL70eggJHgBFETx0mcA0K8qlbdVj0UqTfjJ6zU7i7JLmgP_CV-IzN5bIWA3nrgmthRJvlmxvY8PoBn3CfSJN7Fmcx5LGyWxqYQMkazIKhuMk9C211_VO7vy6Oj6mANfg61MJRWOdjE1lC7qaUz8k2K2OFk1IfXs68xsUZRdHWg0OhgseuX33HL1rzaeY__9znnWx8O323HPatAbIXM53EpCx2CKdGxpcZWhqSQRkgfhLOuLEypgwi5zSwuTUIaNPo0Z0QWrC0Q8CHD516Ai4I6i1GqID9YnelQ1EykVV-bk2Rys0FpqYaNi7jA3X0V89_8X0sT8Le17R9x2dbdbV3_3z7UDbjWL6zZm04TbsKan9yCyx3V5vI2_Oii2ygrwyUvs3rR4Oh6SAX8Mp6xPmWNnfg5asbx2DLqTUDpS3XD9MQxS90edL1kbR7skvXBLWaWbI8iCXRixND3u-lJX93Kmi5N8w58PBfZ78L6ZDrx94GlRMsqdJoRo0nmhUHclM5oaSvNtdARpAMglO37shM9yLFq8wMyqToQKQSRakGkeAQvVnNmXVeSM0e_JZytRlJH8fbCtP6segOlnK8y50WeWOEQ29oUpamc4bnxrgipiWBjgJvqzVyjTrEWwdPVbTRQFHXSEz9dtGNEQrXzZQT3OnSv3oTYCWhPHMHLAe6nD_-3QA_OfpcncGX7cG-kRjv7uw_hKiftoybGxQasz-uFfwSX7Lf5uKkft-rL4NN5q8EvzpeF2w |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VFBAX3g9DgUWCE1ix12t7fUAIKBFR2ygHkMppu0-I1MbBTkA58Mf4dez4kQoBvfXA1d61PPY3s7M7jw_gKbURV5E1YcJTGjKdxKHKGA-9WWBYN5lGrumuv59PJvzwsJhuwc--FgbTKnub2BhqU2o8Ix9ixM5P9vowdF1axHR39GrxNUQGKYy09nQaLUT27Pq7377VL8e7_l8_o3T07sPb92HHMBBqxtNlmPNMOqdyv8jFShcKJeKKceuY0SbPVC4dc6lOtHdTXOykX9-MYonTOvPgd4l_7gXY9i45owPYno4Ppp82JzwYQ2Nx0VXqRAkf1l52rGijLMz8Xr8I6W-rYUMa8DdP948obbP4ja79z5_tOlztXG7yutWRG7Bl5zfhUkvCub4FP9q4t5ebeGeYaLmq_eiqTxL8MluQLpmNnNil15njmSbYtQATm6qayLkhGvtAyGpNmgzZNenCXkStyQHGGPAsiXivwJQnXd0rqdsEztvw8VxkvwODeTm394DESNjKZJwg10limYq8M2mU5LqQVDIZQNyDQ-iuYzsShxyLJnMg4aIFlPCAEg2gBA3g-WbOou1XcuboN4i5zUjsNd5cKKvPojNdwtgiMZalkWaGsUiqLFeFUTRV1mQuVgHs9NATnQGsxSnuAniyue1NF8aj5NyWq2YMi7CqPg_gbov0zZsgbwHulgN40UP_9OH_Fuj-2e_yGC579Iv98WTvAVyhqIjY3TjbgcGyWtmHcFF_W87q6lGnywSOzlsPfgGpcZAk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessing+the+causal+relationship+between+metabolic+biomarkers+and+coronary+artery+disease+by+Mendelian+randomization+studies&rft.jtitle=Scientific+reports&rft.au=Yang%2C+Kai&rft.au=Li%2C+Jixin&rft.au=Hui%2C+Xiaoshan&rft.au=Wang%2C+Wenru&rft.date=2024-08-16&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=14&rft.issue=1&rft.spage=19034&rft_id=info:doi/10.1038%2Fs41598-024-69879-2&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |